Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.4316USD
−8.53 MUSD
24.76 M
About MYDECINE INNOVATIONS GROUP INC.
Sector
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
Employees (FY)
3
Founded
2013
FIGI
BBG00864XZL0
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
MYCO finally movingMyco finally broke out of the downward trend. I am expecting it to restest the 200ma on the daily chart.
My targets:
.32
.395
.435
Bullish PennantI can see this hitting as high as 0.69 cents a share should we break through to the upside. RSI over 50.
Mydecine Innovations Group Bull RunLT’s Comments : Let’s take a look at Mydecine Innovations Group logically and not just go crazy on what is being published out there for investors. We will go through its performance and its capability of real market price. How far can this company go?
SEC Financial Filing
Sept 30,2020
Current: $
MYCO - Next Move? MYCO has formed a prefect cup & handle on the daily
- 4 hits against an important 0.60 resistance
- handle dropped perfectly on the 0.5 fib support level
- price is currently consolidating right below resistance
Fundamentals in the psychedelic space are lining up perfectly for a MYCO breakout.
- t
MYCO she will be ready to pop very soonThe way I see it ....is myco should be making another run in the next couple of days heading towards the $1.10 mark, my guess is it will make it there within 2 weeks. What do you see?
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MYCOF is 0.0221 USD — it has increased by 72.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MYDECINE INNOVATIONS GROUP INC NEW stocks are traded under the ticker MYCOF.
MYDECINE INNOVATIONS GROUP INC NEW is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
MYCOF stock is 156.86% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC NEW there?
MYCOF earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.72 USD resulting in a 65.00% surprise. The estimated earnings for the next quarter are −0.74 USD per share. See more details about MYDECINE INNOVATIONS GROUP INC NEW earnings.
Yes, you can track MYDECINE INNOVATIONS GROUP INC NEW financials in yearly and quarterly reports right on TradingView.
MYCOF stock has risen by 76.72% compared to the previous week, the month change is a 268.17% rise, over the last year MYDECINE INNOVATIONS GROUP INC NEW has showed a 92.44% decrease.
MYCOF net income for the last quarter is −870.77 K USD, while the quarter before that showed −2.40 M USD of net income which accounts for 63.72% change. Track more MYDECINE INNOVATIONS GROUP INC NEW financial stats to get the full picture.
No, MYCOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC NEW stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 3.00 employees. See our rating of the largest employees — is MYDECINE INNOVATIONS GROUP INC NEW on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC NEW technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC NEW stock shows the sell signal. See more of MYDECINE INNOVATIONS GROUP INC NEW technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.